Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Israel Legalizes Export Of Medical Marijuana

JERUSALEM (JTA) — Israel is going into the medical marijuana export business — if its Cabinet agrees.

The Knesset has passed legislation that would have Israel join the Netherlands and Canada as nations allowing the legal export of medical cannabis.

Among the countries reportedly eager to trade with Israel include Australia, Germany, Austria and Mexico, according to Forbes.

“Israel is perfectly positioned to enter and disrupt the medical cannabis market that is expected to soar to $33 billion worldwide in the next 5 years,” Saul Kaye, CEO of iCAN, an Israeli medical cannabis company, said in a statement. “In Israel alone, we quickly expect over $1 billion in sales to countries interested in our products.”

The Cabinet still must approve the legislation. Exports would not begin for at least six months.

The Knesset rushed to vote Tuesday on the measure a day before the parliament dissolved itself. Only 21 of the 120 members in the body voted, Globes reported.  

The legislation, which regulates export procedures, had the support of several key ministries.

There are eight cannabis growing companies operating in Israel and several others involved in production, marketing and distribution. Dozens of other farmers hold licenses to grow cannabis, but have delayed planting as the export legislation has been considered.

A message from our Publisher & CEO Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.